OcellO

OcellO delivers relevant preclinical data to drug developers using 3D cell culture and high content screening technologies.

[OcellO @OcellO_3D]

Heads up for Michiel Fokkelman, OcellO's Head of High Throughput Screening, who stands behind advancing OcellO's automation technology. @crownbioscience

[OcellO @OcellO_3D]

Meet OcellO's Head of IT Ashgard Weterings whose team helps OcellO to deliver to the customers rich data on their compounds with a special focus on speed and quality.

[OcellO @OcellO_3D]

We are inviting you to the 2021 Virtual 3D Cell Culture Summit, where Mariusz Madej, Senior Scientist Oncology and Head of Biobanking, will present OcellO's unique screening platform. #CrownBio

Register today and join us on June 16th, 12:15-12:45pm CEST: https://t.co/tpHPEEtlxS

[OcellO @OcellO_3D]

Mariusz Madej, OcellO's Senior Scientist Oncology and Head of Biobanking, has been the driving force behind growing OcellO's organoid collection. Mariusz leads the effort in new models' establishment and expansion of existing collections as well as multiple commercial projects.

[OcellO @OcellO_3D]

Heads up for Cinthya Del Angel Zuvirie, OcellO's Associate Scientist, bringing great enthusiasm and passion to set up new and expanding existing organoid models for 3D high-throughput-screening assays.

[OcellO @OcellO_3D]

Meet Hester Bange, OcellO's Senior Scientist, Head of Cystopathic Diseases, who shows that OcellO keeps physiological relevance of models and data-rich read-outs hand to hand, and at the same time creates a motivating environment for scientists to work and grow.

[OcellO @OcellO_3D]

Today we celebrate National #Secretary Day in the Netherlands, and for that, we would like to recognize our office manager Henriette Ouwehand, whose daily support is essential for OcellO's team!

[OcellO @OcellO_3D]

Meet OcellO's Senior Director, Head of Immuno-Oncology Lidia Daszkiewicz whose team is making it possible to test a diverse range of immunotherapies focusing on different immune compartments and targeting diverse cancer indications!

[OcellO @OcellO_3D]

OcellO offers compound testing services using co-cultures of cancer and immune cells. Diverse cultured tumor tissues can be used in these assays. So, can you guess which tumor tissue is in this picture?

Learn more here: https://t.co/YuOcVrWv4L

[OcellO @OcellO_3D]

OcellO created a fully scalable platform for automated handling of organoids and compounds, 3D imaging, and 3D image analysis. The result is a unique screening platform for efficient testing of new drugs and drug combinations in state-of-the-art biological models.

[OcellO @OcellO_3D]

We are turning beautiful biology, like in this image of organoid and immune cell co-culture, into meaningful data that helps to make decisions in the drug development journey.
Find out how we do it in one of our publications: https://t.co/s7kmjOY6bk

[OcellO @OcellO_3D]

This work was carried out in collaboration with #HubrechtOrganoidTechnology, #MerckHealthcareKGaA and #CardiffUniversity

#research #cancerresearch #collaboration #organoid #ocellobv #3Dinvitro #3Dscreening

[OcellO @OcellO_3D]

Looking for a good weekend read?
Our recent paper investigating the effects of Tankyrase inhibitors on colorectal #cancer #organoids shows how #imageanalysis reveals subtle alterations consistent with effects on stem cell subpopulations.
Have a read here https://t.co/ppUXnFnaZ3

[World Preclinical Congress @WPC_Congress]

Secure your spot now to hear from @OcellO_3D & HUB Organoid about the features that preserve the genetic & phenotypic characteristics of the original tumor in our upcoming #webinar: https://t.co/a8lxIGzyCN #DrugDiscovery

[OcellO @OcellO_3D]

Join to our interesting sessions in the upcoming virtual #EORTC #NCI #AACR Symposium !

#ocellobv #3Dinvitro #immunooncology #oncology #drugdiscovery

[OcellO @OcellO_3D]

OcellO's Picture of the Month is here ! #CRC #organoids co-cultured with #cancer associated #fibroblasts (CAFs) in #3D, greatly captured.

#ocellobv #organoids #CAFs #3Dinvitro

[OcellO @OcellO_3D]

Check out the article in https://t.co/vkcXTmJGd7 on animal model alternatives, with a spotlight on 3D cell culture and organoid technology from OcellO and organ-on-a-chip technology from our neighbours, @MIMETAS_3D

[Guru Singh @gursatya]

The future of drug testing is more economical and ethical. Bioprinting, organoids and organ-on-a-chip techs are making this possible. Notable players include @Poietis, Organovo, @CELLINK3D, @ctibiotech, @OcellO_3D, @MIMETAS_3D.

@Labiotech_eu https://t.co/1OnYUyTf81

[OcellO @OcellO_3D]

#ADPKD patient kidney tissue cultured #invitro in #3D ! OcellO is leading the way in #3Dinvitro compound testing in ADPKD, which is a devastating disease with no current cure.

#ocellobv #PKD #ADPKD #invitro3D

[EIT Health Belgium-Netherlands @EITHealth_nl]

Congratulations to @aparitohealth #ATROMedical #Ergotrics @fibricheck @OcellO_3D #Phlecs #ProtinhiTherapeutics for being selected for EIT Health’s Bridgehead Global programme.
We wish you all a great journey in reaching markets beyond Europe!

#EITHealth #SME

[OcellO @OcellO_3D]

SAVE THE DATE to join OcellO's ''3D in vitro drug testing for Polycystic Kidney Disease'' webinar on the 2nd of June, Tuesday at 16.30-17.10 CEST (including live Q&A). Interested!? Register here: https://t.co/0UP3Mh6eYS

Looking forward to seeing you.

#PKD #3Dinvitro #ocellobv